Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.
about
Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells.Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosisMyofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease.Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia.Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.DNA and inflammatory mediators in bronchoalveolar lavage fluid from children with acute inhalational injuries.Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis.Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathwayNovel end points for clinical trials in young children with cystic fibrosisEpigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling.Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions.Decreased TGF-β1 and VEGF Release in Cystic Fibrosis Platelets: Further Evidence for Platelet Defects in Cystic Fibrosis.Constrictive Bronchiolitis in Cystic Fibrosis Adolescents with Refractory Pulmonary Decline.Strategies for the etiological therapy of cystic fibrosis.microRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia.TGFβ as a therapeutic target in cystic fibrosis.Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.TGF-β1 Suppresses the Type I IFN Response and Induces Mitochondrial Dysfunction in Alveolar Macrophages.Peripheral Protein Quality Control as a Novel Drug Target for CFTR Stabilizer
P2860
Q34721046-F4F18574-CDD1-465C-B16F-A167722D66ACQ34755463-25E0807C-2083-4697-89F8-178BA232481DQ34946558-324B341C-FB72-4637-AF8B-03479F843C4EQ35223657-0DFCF653-7287-4F03-AD36-BB3EA17BFE08Q35287714-B30980D9-6591-40CC-9451-DB4199C355F1Q35565168-C6BFA289-2EC1-49D7-B71E-8AD56BA44E28Q36594975-AF994CD5-3131-4DAD-86E6-4B97ABBEEDEBQ36675133-31AB7D87-4F27-4F25-BAB4-3C7366FDC3CFQ37162991-261305DF-DE81-497B-B353-DACB28B22375Q37234581-D4ACB476-7A36-407D-964B-0D2AE45C4A90Q38111791-910EFDD0-B26A-45E1-91E4-5509140F3347Q38870958-A74F7D75-81DB-44D0-9DCC-B462FB2F3418Q39093281-3E7A6E4E-52FD-4DAF-907E-7ECF1AC47171Q39595211-7596221F-2E14-4749-91D3-E3C2BC5C5D2CQ40560942-A3BDA76F-BEB9-4109-9897-232E64C198BFQ42650380-6EF61D1A-7117-42C2-963C-22D841C0B93DQ47302859-72551BD9-B639-4BA6-AB00-60AA0DEDE056Q47822059-F0875826-6593-4EAD-8173-BD55447A96ECQ47831284-9BB2EE4D-8C71-4FBD-A026-4FB0DA93BCB4Q50088156-41667582-A625-429D-9D48-B77C1936E771Q57490973-31AFCF4D-E542-44DB-8CFF-C73A7D0DB796
P2860
Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Plasma TGF-β₁ in pediatric cys ...... sease and response to therapy.
@en
type
label
Plasma TGF-β₁ in pediatric cys ...... sease and response to therapy.
@en
prefLabel
Plasma TGF-β₁ in pediatric cys ...... sease and response to therapy.
@en
P2093
P2860
P356
P1476
Plasma TGF-β₁ in pediatric cys ...... isease and response to therapy
@en
P2093
J P Clancy
Marianne S Muhlebach
Michael R Knowles
Terry L Noah
William T Harris
P2860
P304
P356
10.1002/PPUL.21430
P577
2011-02-18T00:00:00Z